Morningstar Investment Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
BPC
DLA
LIM
OIAM
LSA
SO
Morningstar Investment Management's MRNA Position: Q2 2026 in Review
Morningstar Investment Management held its Moderna (MRNA) position steady in Q2 2026 at 73,982 shares worth $3.76M. The position accounts for 0.23% of the portfolio, ranked #106.
Morningstar Investment Management first reported a position in MRNA in Q3 2025 and has held it in 4 quarters since. 302 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Morningstar Investment Management held 73,982 shares of Moderna worth $3.76M as of Q2 2026.
- Morningstar Investment Management left its Moderna share count unchanged in Q2 2026.
- Moderna made up 0.23% of Morningstar Investment Management's portfolio in Q2 2026, its #106 holding.
- Morningstar Investment Management first reported a position in Moderna in Q3 2025 and has held it in 4 quarters since.
- 302 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Morningstar Investment Management's 13F filing for Q2 2026, filed 21 Jul 2026.